Last reviewed · How we verify
AZD-3043
At a glance
| Generic name | AZD-3043 |
|---|---|
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043 (PHASE1)
- AZD Single Ascending Dose Study In Healthy Japanese Subjects (PHASE1)
- Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043 (PHASE1)
- Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AZD-3043 CI brief — competitive landscape report
- AZD-3043 updates RSS · CI watch RSS